Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for methylprednisolone in Related Substance Name (approximate match)

Showing 21 - 30 of 41 results

First page
Previous page
3
Next page
Next page

METHYLHYDROCORTISONE-21-HYDROGEN HEMISUCCINATE

BM23AP4A2H

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

(6.ALPHA.,11.BETA.,20S)-11,17,20-TRIHYDROXY-6-METHYL-3-OXOPREGNA-1,4-DIEN-21-OIC ACID

D6B7O7187C

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

11.BETA.-HYDROXY-6.ALPHA.-METHYL-3-OXOANDROSTA-1,4-DIENE-17.BETA.-CARBOXYLIC ACID

I3082IBD9A

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

11.BETA.-HYDROXY-6.ALPHA.-METHYLANDROSTA-1,4-DIENE-3,17-DIONE

UP4NO9901H

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

11-DEOXY-20-HYDROXY METHYLPREDNISOLONE

4IL21793D6

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (EPIMERIC)

17-DEOXY-20-HYDROXY METHYLPREDNISOLONE

2DVV21959V

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (EPIMERIC)

6,7-DIDEHYDRO-11-KETO METHYLPREDNISOLONE

7S5HEH87YT

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

6.ALPHA.-METHYLHYDROCORTISONE 21-ACETATE

38Y9UQL8SN

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

METHYLPREDNISOLONE 17-HEMISUCCINATE

B8V07359RT

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

6.ALPHA.-METHYLPREDNISONE

621XR2W6OP

Search for Structure

Status:

Possibly Marketed Outside US

Source:

NCT00371826: Phase 4 Interventional Completed Renal Transplanted Recipients

(2006)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00371826

Class (Stereo):

CHEMICAL (ABSOLUTE)

11-keto methylprednisolone is a metabolite of corticosteroid immunosuppressant methylprednisolone.

Structure of METHYLHYDROCORTISONE-21-HYDROGEN HEMISUCCINATE

ABSOLUTE

METHYLHYDROCORTISONE-21-HYDROGEN HEMISUCCINATE

Structure of (6.ALPHA.,11.BETA.,20S)-11,17,20-TRIHYDROXY-6-METHYL-3-OXOPREGNA-1,4-DIEN-21-OIC ACID

ABSOLUTE

(6.ALPHA.,11.BETA.,20S)-11,17,20-TRIHYDROXY-6-METHYL-3-OXOPREGNA-1,4-DIEN-21-OIC ACID

Structure of 11.BETA.-HYDROXY-6.ALPHA.-METHYL-3-OXOANDROSTA-1,4-DIENE-17.BETA.-CARBOXYLIC ACID

ACHIRAL

11.BETA.-HYDROXY-6.ALPHA.-METHYL-3-OXOANDROSTA-1,4-DIENE-17.BETA.-CARBOXYLIC ACID

Structure of 11.BETA.-HYDROXY-6.ALPHA.-METHYLANDROSTA-1,4-DIENE-3,17-DIONE

ACHIRAL

11.BETA.-HYDROXY-6.ALPHA.-METHYLANDROSTA-1,4-DIENE-3,17-DIONE

Structure of 11-DEOXY-20-HYDROXY METHYLPREDNISOLONE

EPIMERIC

11-DEOXY-20-HYDROXY METHYLPREDNISOLONE

Structure of 17-DEOXY-20-HYDROXY METHYLPREDNISOLONE

EPIMERIC

17-DEOXY-20-HYDROXY METHYLPREDNISOLONE

Structure of 6,7-DIDEHYDRO-11-KETO METHYLPREDNISOLONE

ABSOLUTE

6,7-DIDEHYDRO-11-KETO METHYLPREDNISOLONE

Structure of 6.ALPHA.-METHYLHYDROCORTISONE 21-ACETATE

ABSOLUTE

6.ALPHA.-METHYLHYDROCORTISONE 21-ACETATE

Structure of METHYLPREDNISOLONE 17-HEMISUCCINATE

ABSOLUTE

METHYLPREDNISOLONE 17-HEMISUCCINATE

Structure of 6.ALPHA.-METHYLPREDNISONE

ABSOLUTE

6.ALPHA.-METHYLPREDNISONE

Showing 21 - 30 of 41 results

First page
Previous page
3
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1